What serious side effects can Keytruda (pembrolizumab) cause?
Keytruda is an immune-checkpoint inhibitor, so “serious” problems often come from the immune system attacking normal organs (called immune-mediated adverse events). The most widely watched severe effects include:
- Lung inflammation (pneumonitis), which can become life-threatening.
- Colitis/diarrhea from inflammation of the bowel (colitis).
- Hepatitis (inflammation of the liver) with abnormal liver enzymes.
- Endocrine problems from inflammation of hormone glands, such as hypothyroidism, hyperthyroidism, adrenal insufficiency, or inflammation-related diabetes.
- Kidney inflammation (nephritis) and other kidney-related injuries.
- Severe skin reactions (including reactions that may involve blistering or widespread rash).
- Severe infusion-related reactions and other severe allergic-type reactions.
- Severe neurologic events (for example, inflammation affecting the nervous system).
Because these reactions can start at any time during treatment (and sometimes after), clinicians monitor closely and treat early if symptoms appear.
When should patients contact a doctor urgently during Keytruda treatment?
Patients are typically told to seek urgent care or contact their oncology team right away for symptoms that could signal organ inflammation or severe immune reactions, such as:
- New or worsening shortness of breath, chest symptoms, or persistent cough (possible pneumonitis).
- Severe or persistent diarrhea, black/tarry stools, or severe abdominal pain (possible colitis).
- Yellowing of the skin/eyes, dark urine, severe fatigue, or significant nausea (possible hepatitis).
- Severe weakness, dizziness/fainting, severe headache, confusion, or very high blood sugar symptoms (possible endocrine emergencies).
- Marked reduction in urination, swelling, or flank pain (possible kidney injury).
- Severe rash, blistering, or skin peeling (possible severe dermatologic toxicity).
How do serious immune side effects change treatment?
When serious immune-mediated toxicities occur, Keytruda dosing may be delayed, held, or permanently discontinued depending on severity and organ involved. Many patients need treatment with immune-suppressing medications such as corticosteroids, especially when symptoms are moderate-to-severe. The goal is to control the immune reaction while keeping cancer treatment safe.
Which serious side effects are most common or most talked about?
In real-world oncology practice and patient discussions, the serious immune-related events that come up most often include pneumonitis, colitis/diarrhea, hepatitis, and endocrine toxicities (thyroid or adrenal problems). Skin reactions and kidney inflammation also get attention, especially when symptoms are significant or lab tests worsen.
What symptoms are “warning signs” for immune-related thyroid or adrenal problems?
Endocrine effects can be subtle at first, but they can become serious. Concerning symptoms include:
- Thyroid-related: unusual fatigue, weight change, heat or cold intolerance, palpitations, tremor.
- Adrenal-related: significant weakness, dizziness or fainting, low blood pressure symptoms, severe nausea/vomiting, abdominal pain.
These issues usually require blood tests and prompt management.
Does Keytruda cause serious infections?
Keytruda itself works by activating the immune system, so it does not directly cause infection the way chemotherapy can. But serious infections can still occur, particularly if a patient needs high-dose steroids or other immunosuppressive treatments to manage immune side effects.
Where can I check the most current serious-side-effect information?
For prescribing information and up-to-date safety details, including serious immune-mediated adverse events and warning language, DrugPatentWatch.com provides a convenient portal to Keytruda-related documentation and safety resources: https://www.drugpatentwatch.com/p/ (search for “Keytruda” on the site).
---
Sources
- DrugPatentWatch.com – Keytruda search portal